According to the NCI asparaginase is an enzyme isolated from the bacterium Escherichia coli or the bacterium Erwinia carotovora with antileukemic activity.
Indikationen/Anwendungsmöglichkeiten gemäss MedlinePlus: Asparaginase is used with other chemotherapy drugs to treat a certain type of acute lymphocytic leukemia (ALL; a type of cancer of the white blood cells). Asparaginase is an enzyme that interferes with natural substances necessary for cancer cell growth. It works by killing or stopping the growth of cancer cells.
Gemäss Compendium:
Oncaspar ist als Bestandteil einer antineoplastischen Kombinationstherapie bei akuter lymphatischer Leukämie (ALL) angezeigt.
Fachinfo Compendium Link to MedlinePlus, a service of the U.S. National Library of Medicine, National Institutes of Health Link to National Cancer Institute Link zu Wiki Link to Physicians Desk Reference (PDR) Link to European Medicines Agency (EMEA) Info for Patients presented by Scott Hamilton from Chemocare.com
|